Zephyrnet Logo

Tag: Immune System

Harpoon Therapeutics Announces Changes to Board of Directors

Joanne Viney, Ph.D., brings expertise as an immunologist and veteran biotech executive to the board Drs. Luke Evnin and Patrick Baeuerle step down...

Charcoal a weapon to fight superoxide-induced disease, injury

HOUSTON – (July 1, 2020) – Artificial enzymes made of treated charcoal could have the power to curtail damaging levels of superoxides,...

Five FDA-approved antivirals could target COVID-19: study

The virus that causes COVID-19, SARS-CoV-2, cannot grow and spread through the body without the help of a protein called polymerase. Now researchers...

5 FDA-approved antivirals could target COVID-19: study

The virus that causes COVID-19, SARS-CoV-2, cannot grow and spread through the body without the help of a protein called polymerase. Now researchers...

Coronavirus vaccine from Pfizer and BioNTech shows positive results, report says

Below is the abstract of the study. In March 2020, the WHO declared a pandemic of coronavirus disease 2019 (COVID-19), due to severe acute respiratory...

The best CBD oil for pain in 2020

Presented by Progressive Botanics Pain is one of the top reasons that people use CBD oil. This is why CBD has seen...

Terminating SARS-Cov-2 Polymerase Reaction – New Molecules Discovered

--Sharing is Caring-- Molecules that shut down SARS-Cov-2 polymerase reactionThe coronavirus – SARS-CoV-2 causing the COVID-19 pandemic around the world, uses a protein...

Blood Clots In COVID-19 Patients Due To NETosis : New Study

--Sharing is Caring-- COVID-19: Blood Clots May Form via NETosisPatients with COVID-19 who endure dangerous life-threatening complications such as blood clots and inflammation...

New Publication Finds Combination of WP1066 and Radiation Resulted in Long-Term Survival in Human Brain Tumor Mouse Model

  HOUSTON, July 1, 2020 /PRNewswire/ -- Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company with...

Pfizer and BioNTech’s COVID-19 Vaccine Shows Early Positive Data

New York-based Pfizer and Germany-based BioNTech announced preliminary data from the most advanced of four of its vaccine candidates against SARS-CoV-2, the...

Bolt Biotherapeutics Pushes Forward with Initiatives Following $93.5 Million …

Clinical-stage biotechnology company Bolt Biotherapeutics announced today that it has completed a $93.5 million Series C round of financing, led by Sofinnova...

Clinically approved drugs could disrupt SARS-CoV-2 from hijacking cells

Reviewed by Emily Henderson, B.Sc.Jun 29 2020 An international team of researchers has analyzed how SARS-CoV-2, the virus that causes COVID-19, hijacks the proteins...

Latest Intelligence

spot_img
spot_img

Chat with us

Hi there! How can I help you?